Lanzamiento Enero 2027

Estudio2022Financiación no declaradaSolo mecanismos

Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19

Khanal P, Chikhale R, Dey YN, Pasha I, Chand S, Gurav N, Ayyanar M, Patil BM, Gurav S

Journal of biomolecular structure & dynamics · 37 citas

Etiquetas de revisión

Financiación no declaradaSolo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
Estudiado en
Células o muestras de laboratorio
Resultado principal
Solo mecanismos

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2021-01-18 · J Biomol Struct Dyn · vol. 40 · número 12 · págs. 5295–5308
Editorial
Taylor & Francis
Citado
64 citas · más que el 98% de estudios similares · 7.6× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
52 trabajos
Acceso
De pago
Áreas de investigación
Computational Drug Discovery Methods · Phytochemicals and Medicinal Plants · Diverse Scientific Research Studies
Palabras clave
Withanolide, Withania somnifera, Withaferin A, Chemistry, Biology, Biochemistry, Medicine
MeSH
humans, withania, withanolides, spike glycoprotein, coronavirus, covid-19 drug treatment

9 autores

  • Pukar Khanal🇮🇳KLE Academy of Higher Education and Research
  • Rupesh V. Chikhale🇬🇧University of East Anglia
  • Yadu Nandan Dey🇮🇳Adamas University
  • Ismail Pasha🇪🇷University of Asmara
  • Sharad Chand🇮🇳Nitte University
  • Nilambari S. Gurav🇮🇳Goa University
  • Muniappan Ayyanar🇮🇳Bharathidasan University; A. Veeriya Vandayar Memorial Sri Pushpam College
  • B. M. Patil🇮🇳 · autor de correspondenciaKLE Academy of Higher Education and Research
  • Shailendra Shivaji Gurav🇮🇳 · autor de correspondenciaGoa University; Goa Medical College

Resumen

El texto original del estudio, en el idioma en que se publicó.

Traditionally, Withania somnifera is widely used as an immune booster, anti-viral, and for multiple medicinal purposes. The present study investigated the withanolides as an immune booster and anti-viral agents against the coronavirus-19. Withanolides from Withania somnifera were retrieved from the open-source database, their targets were predicted using DIGEP-Pred, and the protein-protein interaction was evaluated. The drug-likeness score and intestinal absorptivity of each compound were also predicted. The network of compounds, proteins, and modulated pathways was constructed using Cytoscape, and docking was performed using autodock4.0, and selected protein-ligand complexes were subjected to 100 ns Molecular Dynamics simulations. The molecular dynamics trajectories were subjected to free energy calculation by the MM-GBSA method. Withanolide_Q was predicted to modulate the highest number of proteins, showed human intestinal absorption, and was predicted for the highest drug-likeness score. Similarly, combined network interaction identified Withanolide_Q to target the highest number of proteins; RAC1 was majorly targeted, and fluid shear stress and atherosclerosis associated pathway were chiefly regulated. Similarly, Withanolide_D and Withanolide_G were predicted to have a better binding affinity with PLpro, Withanolide_M with 3CLpro, and Withanolide_M with spike protein based on binding energy and number of hydrogen bond interactions. MD studies suggested Withanoside_I with the highest binding free energy (ΔGbind-31.56 kcal/mol) as the most promising inhibitor. Among multiple withanolides from W. somnifera, Withanolide_D, Withanolide_G, Withanolide_M, and Withanolide_Q were predicted as the lead hits based on drug-likeness score, modulated proteins, and docking score to boost the immune system and inhibit the COVID-19 infection, which could primarily act against COVID-19. HighlightsWithanolides are immunity boosters.Withanolides are a group of bio-actives with potential anti-viral properties.Withanolide_G, Withanolide_I, and Withanolide_M from Withania somnifera showed the highest binding affinity with PLpro, 3CLpro, and spike protein, respectively.Withanolides from Withania somnifera holds promising anti-viral efficacy against COVID-19.Communicated by Vsevolod Makeev.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.